We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Vitamin D Status Determined in Older Adults

By LabMedica International staff writers
Posted on 25 Jun 2019
Print article
Image: The complete extraction-free, fully automated Liaison XL 1,25 dihydroxyvitamin D radioimmunoassay kit (Photo courtesy of DiaSorin).
Image: The complete extraction-free, fully automated Liaison XL 1,25 dihydroxyvitamin D radioimmunoassay kit (Photo courtesy of DiaSorin).
Vitamin D has a known role in bone health, with growing evidence for beneficial effects on muscle strength and other non-skeletal outcomes. Vitamin D deficiency is often associated with adverse health outcomes in older adults. The circulating 25-hydroxyvitamin D (25(OH)D) status predominately relies on UV exposure.

Several known age-related adverse health outcomes, including bone loss, fracture risk, and falls, are associated with suboptimal serum 25-hydroxyvitamin D (25(OH)D) status (the main circulating and diagnostic metabolite of vitamin D) with further evidence for non-skeletal roles in carcinogenesis, immune function, cardiovascular disease, dementia, and all-cause mortality.

Irish scientists led by those at Trinity College (Dublin, Ireland) investigated vitamin D deficiency in community-dwelling, older adults, residing at latitudes 50⁰–55⁰ north and the study included 6,004 adults, aged over 50 years. Deficiency was categorized by two criteria: Institute of Medicine (IOM) (<30 nmol/L) and Endocrine Society (ES) (<50 nmol/L). Serum 25(OH)D was assessed from a fasting blood sample and concentrations of 25(OH)D were analyzed using the Liaison 25-hydroxyvitamin D immunoassay which yields a lower detection limit of 3.0 nmol/L.

The investigators reported that overall, the prevalence of deficiency (<30 nmol/L and <50 nmol/L) was 23.7% and 55.3%, respectively. For older age categories of ≥60 years and ≥65 years, vitamin D deficiency (<30 nmol/L) and deficiency (<50 nmol/L) were similar at 22.6% and 22.5% and 54.2% and 53.9%, respectively. The highest prevalence of deficiency (by IOM) was noted in women aged 80 years and older (36.8%), with the lowest in men aged between 70–79 years (17.3%). The overall mean 25(OH)D was 48.7 ± 23.5 (range; 9–239 nmol/L). Residing in the south of England was associated with a 22.8% lower risk of deficiency.

Maria O'Sullivan, PhD, an Associate Professor in Nutrition and a senior author of the study, said, “'Our study identified factors associated with vitamin D deficiency, including being aged 80+ years, obesity and sedentary lifestyles; all of which are increasing traits in western populations. Furthermore, this is one of the few studies to highlight the importance of non-white ethnicity in vitamin D deficiency in a large study of ageing. The findings are valuable in developing targeted strategies to eliminate vitamin D deficiency (at 30nmol/L) in older populations.”

The authors concluded that the high prevalence of vitamin D deficiency identified in the cohort highlights the need to raise awareness and have adequate public health strategies for achieving optimum vitamin D concentrations to support successful ageing. Based on their findings, there is a particular need to raise awareness and target those most at risk of vitamin D deficiency. The study was published on June 1, 2019, in the journal Nutrients.

Related Links:
Trinity College

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Molecular Diagnostics

view channel
Image: Liquid biopsy could detect and monitor aggressive small cell lung cancer (Photo courtesy of Shutterstock)

Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer

Small cell lung cancer (SCLC) is a highly aggressive type of cancer known for its ability to metastasize. The behavior of tumors is largely governed by which genes are turned on, or transcribed, irrespective... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.